These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17331078)

  • 1. Epistatic interactions between genomic regions containing the COL1A1 gene and genes regulating osteoclast differentiation may influence femoral neck bone mineral density.
    Yang TL; Shen H; Xiong DH; Xiao P; Guo Y; Guo YF; Liu YZ; Recker RR; Deng HW
    Ann Hum Genet; 2007 Mar; 71(Pt 2):152-9. PubMed ID: 17331078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
    Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J
    J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis of bone mineral density and single nucleotide polymorphisms in two candidate genes on chromosome 1p36.
    Spotila LD; Rodriguez H; Koch M; Tenenhouse HS; Tenenhouse A; Li H; Devoto M
    Calcif Tissue Int; 2003 Aug; 73(2):140-6. PubMed ID: 14565595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density.
    Ota N; Nakajima T; Nakazawa I; Suzuki T; Hosoi T; Orimo H; Inoue S; Shirai Y; Emi M
    J Hum Genet; 2001; 46(5):267-72. PubMed ID: 11355017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic regions identified for BMD in a large sample including epistatic interactions and gender-specific effects.
    Xiao P; Shen H; Guo YF; Xiong DH; Liu YZ; Liu YJ; Zhao LJ; Long JR; Guo Y; Recker RR; Deng HW
    J Bone Miner Res; 2006 Oct; 21(10):1536-44. PubMed ID: 16995807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
    Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
    J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a polymorphism in the TNFR2 gene with low bone mineral density.
    Spotila LD; Rodriguez H; Koch M; Adams K; Caminis J; Tenenhouse HS; Tenenhouse A
    J Bone Miner Res; 2000 Jul; 15(7):1376-83. PubMed ID: 10893687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of osteoporosis.
    Williams FM; Spector TD
    Acta Reumatol Port; 2007; 32(3):231-40. PubMed ID: 17940498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the genetics of osteoporosis.
    Williams FM; Spector TD
    J Musculoskelet Neuronal Interact; 2006; 6(1):27-35. PubMed ID: 16675887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck bmd in Spanish postmenopausal women.
    Bustamante M; Nogués X; Agueda L; Jurado S; Wesselius A; Cáceres E; Carreras R; Ciria M; Mellibovsky L; Balcells S; Díez-Pérez A; Grinberg D
    Calcif Tissue Int; 2007 Oct; 81(4):327-32. PubMed ID: 17878995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracture.
    Tasker PN; Albagha OM; Masson CB; Reid DM; Ralston SH
    Osteoporos Int; 2004 Nov; 15(11):903-8. PubMed ID: 15071724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women.
    Albagha OM; Tasker PN; McGuigan FE; Reid DM; Ralston SH
    Hum Mol Genet; 2002 Sep; 11(19):2289-95. PubMed ID: 12217957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors regulating circulating vascular endothelial growth factor (VEGF): association with bone mineral density (BMD) in post-menopausal osteoporosis.
    Costa N; Paramanathan S; Mac Donald D; Wierzbicki AS; Hampson G
    Cytokine; 2009 Jun; 46(3):376-81. PubMed ID: 19394248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
    Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects.
    Mangiafico RA; Malaponte G; Pennisi P; Li Volti G; Trovato G; Mangiafico M; Bevelacqua Y; Mazza F; Fiore CE
    J Intern Med; 2007 Jun; 261(6):587-96. PubMed ID: 17547714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of genetic lactase non-persistence and sex with bone loss in young adulthood.
    Laaksonen MM; Impivaara O; Sievänen H; Viikari JS; Lehtimäki TJ; Lamberg-Allardt CJ; Kärkkäinen MU; Välimäki M; Heikkinen J; Kröger LM; Kröger HP; Jurvelin JS; Kähönen MA; Raitakari OT;
    Bone; 2009 May; 44(5):1003-9. PubMed ID: 19168163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of osteoclast differentiation induced by IL-1.
    Kim JH; Jin HM; Kim K; Song I; Youn BU; Matsuo K; Kim N
    J Immunol; 2009 Aug; 183(3):1862-70. PubMed ID: 19587010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotypes of promoter and intron 1 polymorphisms in the COLIA1 gene are associated with increased risk of osteoporosis.
    Husted LB; Harsløf T; Gonzalez-Bofill N; Schmitz A; Carstens M; Stenkjaer L; Langdahl BL
    Calcif Tissue Int; 2009 Feb; 84(2):85-96. PubMed ID: 19082910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.